Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine

John Litt; Susan Kim; Richard Woodman; Raina MacIntyre; Tony Cunningham

doi:10.1016/j.ijid.2014.03.1320

Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine

John Litt, Susan Kim, Richard Woodman, Raina MacIntyre, Tony Cunningham

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

Background: Shingles causes considerable morbidity in older persons. Zostavax, a vaccine against shingles, reduces the incidence of shingles by 50% and the burden of illness by two-thirds. Little is known about the factors that contribute to the patient's intention to get Zostavax. Methods & Materials: A two stage simple random sampling process was undertaken to identify a random sample of GPs across two urban areas in South Australia to identify the key beliefs about shingles and its complications and the factors that may influence the uptake of the Zostavax.

Original language	English
Pages (from-to)	436-437
Number of pages	2
Journal	International Journal of Infectious Diseases
Volume	21
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/j.ijid.2014.03.1320
Publication status	Published - Apr 2014
Event	16th International Congress on Infectious Diseases - Cape Town, South Africa Duration: 2 Apr 2014 → 5 Apr 2014 Conference number: 16

Bibliographical note

This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed.

Keywords

shingles
vaccination
vaccine
older adults
older persons

Access to Document

10.1016/j.ijid.2014.03.1320Licence: CC BY-NC-ND

Published versionFinal published version, 75.8 KBLicence: CC BY-NC-ND

Fingerprint Dive into the research topics of 'Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine'. Together they form a unique fingerprint.

Cite this

@article{f07711f0de3f48a49a40fb9f4d81b2b9,

title = "Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine",

abstract = "Background: Shingles causes considerable morbidity in older persons. Zostavax, a vaccine against shingles, reduces the incidence of shingles by 50% and the burden of illness by two-thirds. Little is known about the factors that contribute to the patient's intention to get Zostavax. Methods & Materials: A two stage simple random sampling process was undertaken to identify a random sample of GPs across two urban areas in South Australia to identify the key beliefs about shingles and its complications and the factors that may influence the uptake of the Zostavax.",

keywords = "shingles, vaccination, vaccine, older adults, older persons",

author = "John Litt and Susan Kim and Richard Woodman and Raina MacIntyre and Tony Cunningham",

note = "This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed.; 16th International Congress on Infectious Diseases, ICID ; Conference date: 02-04-2014 Through 05-04-2014",

year = "2014",

month = apr,

doi = "10.1016/j.ijid.2014.03.1320",

language = "English",

volume = "21",

pages = "436--437",

journal = "International Journal of Infectious Diseases",

issn = "1201-9712",

number = "Supplement 1",

}

Australian zoster study : GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine. / Litt, John; Kim, Susan ; Woodman, Richard; MacIntyre, Raina; Cunningham, Tony.

In: International Journal of Infectious Diseases, Vol. 21, No. Supplement 1, 04.2014, p. 436-437.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Australian zoster study

T2 - 16th International Congress on Infectious Diseases

AU - Litt, John

AU - Kim, Susan

AU - Woodman, Richard

AU - MacIntyre, Raina

AU - Cunningham, Tony

N1 - Conference code: 16

PY - 2014/4

Y1 - 2014/4

N2 - Background: Shingles causes considerable morbidity in older persons. Zostavax, a vaccine against shingles, reduces the incidence of shingles by 50% and the burden of illness by two-thirds. Little is known about the factors that contribute to the patient's intention to get Zostavax. Methods & Materials: A two stage simple random sampling process was undertaken to identify a random sample of GPs across two urban areas in South Australia to identify the key beliefs about shingles and its complications and the factors that may influence the uptake of the Zostavax.

AB - Background: Shingles causes considerable morbidity in older persons. Zostavax, a vaccine against shingles, reduces the incidence of shingles by 50% and the burden of illness by two-thirds. Little is known about the factors that contribute to the patient's intention to get Zostavax. Methods & Materials: A two stage simple random sampling process was undertaken to identify a random sample of GPs across two urban areas in South Australia to identify the key beliefs about shingles and its complications and the factors that may influence the uptake of the Zostavax.

KW - shingles

KW - vaccination

KW - vaccine

KW - older adults

KW - older persons

U2 - 10.1016/j.ijid.2014.03.1320

DO - 10.1016/j.ijid.2014.03.1320

M3 - Meeting Abstract

VL - 21

SP - 436

EP - 437

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

IS - Supplement 1

Y2 - 2 April 2014 through 5 April 2014

ER -